Literature DB >> 19649679

Left ventricular mass from gated SPECT myocardial perfusion imaging: comparison with cardiac computed tomography.

Tochi M Okwuosa1, Chetan V Hampole, Javid Ali, Kim A Williams.   

Abstract

BACKGROUND: Increased left ventricular mass (LVM) has been correlated with adverse cardiac events, such as sudden cardiac death. However, LVM quantitation with widely utilized gated SPECT myocardial perfusion imaging (MPI) software, has little validation and clinical application. Thus, we compared LVM from two commonly employed gated SPECT packages [4D-MSPECT (4DM) and Quantitative Perfusion SPECT (QPS)] with the 3-dimensional reference standard, CT angiography (CTA).
METHODS: Comparisons were made in 56 patients (mean age 61.4 +/- 14.6; 32% female) referred for dual-isotope or low-dose/high-dose Tc-99m-tetrofosmin rest/stress MPI and cardiac CTA (mean 1.5 +/-4.5 months apart). LVM measurement was performed for both CTA and MPI by two independent observers blinded to clinical information.
RESULTS: Correlation with CTA was best for post-stress MPI than at rest; thus, post-stress values are reported. Values obtained with each of the techniques were very highly reproducible (interobserver correlation r = 0.99 for each technique). The mean LVM values were 142 g by CTA, 145 g by 4DM, and 135 g by QPS (P = NS for CTA vs SPECT, but P < .001 for 4DM vs QPS). There was moderately good correlation between CTA and SPECT LVM data (r = 0.74 and 0.72 for 4DM and QPS, respectively; both P < .001). However, on Bland-Altman analysis there was significant overestimation of lower values and underestimation of higher CT LVM values by both QPS and 4DM (both r = 0.68 and 0.69, P < .001). The limits of agreement relative to CT LVM were wide (-52.1 g to 64.1 g for QPS; and -60.0 g to 53.5 g for 4DM).
CONCLUSIONS: SPECT and CTA give reproducible measures of LVM. Using CTA as the reference standard, the mean SPECT LVM values are similar, but lower values are overestimated and higher values are underestimated. Thus, the SPECT values are not substitutable for CTA without mathematical correction.

Entities:  

Mesh:

Year:  2009        PMID: 19649679     DOI: 10.1007/s12350-009-9131-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  27 in total

1.  Left ventricular mass measured by myocardial perfusion gated SPECT. Relation to three-dimensional echocardiography.

Authors:  Ola Akinboboye; Guido Germano; Olajide Idris; Kenneth Nichols; Aasha Gopal; Daniel Berman; Steven R Bergmann
Journal:  Clin Nucl Med       Date:  2003-05       Impact factor: 7.794

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance.

Authors:  Subha V Raman; Mona Shah; Beth McCarthy; Anne Garcia; Amy K Ferketich
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

4.  Quantification of left ventricular function and mass in heart transplant recipients using dual-source CT and MRI: initial clinical experience.

Authors:  Gorka Bastarrika; Maria Arraiza; Carlo N De Cecco; Stefano Mastrobuoni; Matias Ubilla; Gregorio Rábago
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Cardiac functional analysis with multi-detector row CT and segmental reconstruction algorithm: comparison with echocardiography, SPECT, and MR imaging.

Authors:  Masaki Yamamuro; Eiji Tadamura; Shigeto Kubo; Hiroshi Toyoda; Takeshi Nishina; Muneo Ohba; Ryohei Hosokawa; Takeshi Kimura; Nagara Tamaki; Masashi Komeda; Toru Kita; Junji Konishi
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

8.  Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging.

Authors:  T Schlosser; O K Mohrs; A Magedanz; T Voigtländer; A Schmermund; J Barkhausen
Journal:  Acta Radiol       Date:  2007-02       Impact factor: 1.990

9.  Accuracy of ventricular volume and ejection fraction measured by gated myocardial SPECT: comparison of 4 software programs.

Authors:  K Nakajima; T Higuchi; J Taki; M Kawano; N Tonami
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

10.  Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.

Authors:  Wolfgang M Schaefer; Claudia S A Lipke; Bernd Nowak; Hans-Juergen Kaiser; Patrick Reinartz; Arno Buecker; Gabriele A Krombach; Udalrich Buell; Harald P Kühl
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

View more
  6 in total

Review 1.  Echocardiographic quantification of left ventricular mass: prognostic implications.

Authors:  Rajiv S Swamy; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

2.  Highlights of the 2009 Scientific Session of the American Society of Nuclear Cardiology: Minneapolis, Minnesota, October 1-4, 2009.

Authors:  Raymond R Russell; Brian G Abbott; James A Arrighi; Ron Blankstein; Mylan C Cohen; Tracy L Faber; Jennifer H Mieres; Todd D Miller; Peter L Tilkemeier; Mark I Travin; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

Review 3.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Med       Date:  2019-11       Impact factor: 10.057

4.  Assessment of left ventricular mass by SPECT MPI.

Authors:  René R Sevag Packard; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2017-12-14       Impact factor: 5.952

5.  Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance.

Authors:  Alessia Gimelli; Riccardo Liga; Serena Magro; Salvatore Novo; Roberto Pedrinelli; Anna Sonia Petronio; Paolo Marzullo; Alessia Pepe
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952

Review 6.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-10-25       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.